Two Ocular Infections during Conventional Chemotherapy in a Patient with Acute Lymphoblastic Leukemia: A Case Report by Taha, Ruba et al.
 
Case Rep Oncol 2010;3:234–239 
DOI: 10.1159/000318230 
Published online: July 10, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
Dr. Ruba Taha    Department of Hematology and Bone Marrow Transplant 
Al Amal Hospital, Hamad Medical Corporation HMC 
PO Box 3050 
Doha (Qatar) 
Tel. +974 439 7895, Fax +974 4397857, E-Mail rubataha @ yahoo.com, rtaha @ hmc.org.qa
 
234
   
Two Ocular Infections during 
Conventional Chemotherapy in 
a Patient with Acute 
Lymphoblastic Leukemia:  
A Case Report 
Ruba Tahaa    Ibrahim Al Hijjia    Halima El Omria    
Fareed Al-Laftahb    Riham Negma    Mohammed Yassina    
Hanadi El Ayoubi
a  
aDepartment of Hematology and Medical Oncology, Al Amal Hospital, Hamad 
Medical Corporation, and bDepartment of Ophthalmology, Hamad Medical 
Corporation, Doha, Qatar 
 
Key Words 
Cytomegalovirus retinitis · Acute lymphoblastic leukemia · Chemotherapy · Hyper-CVAD · 
Candida 
Abstract 
Viral retinitis due to cytomegalovirus (CMV) infection is rare in patients with acute 
leukemia who did not receive hematopoietic stem cell transplantation. We report a case 
of CMV retinitis that developed in a 49-year-old patient with acute lymphoblastic 
leukemia. The patient was treated with salvage chemotherapy using a hyper-CVAD 
regimen and did not receive hematopoietic stem cell transplantation. The incidence of 
CMV retinitis in this subgroup of patients is not described in literature. He had a very 
complicated course during chemotherapy but was successfully treated, with 
preservation of visual acuity, and to date he is in complete remission. Interestingly, prior 
to CMV retinitis, the patient had been diagnosed with and treated for candida retinitis. 
This case shows the importance of eye examination and care in patients diagnosed with 
hematological malignancies. 
Introduction 
Cytomegalovirus (CMV) or human herpesvirus 5 is a well-known cause of 
opportunistic infection in immunocompromised patients; the infection is especially  
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known in patients with acquired immunodeficiency syndrome (AIDS), organ 
transplantations and hematological malignancies. It is particularly serious after solid 
organ transplantation or allogenic hematopoietic stem cell transplantation (HSCT). 
Without prophylaxis, 8–39% of solid organ transplantation and 20–35% of allogenic 
HSCT recipients develop CMV infection [1]. In the eye, CMV presents as a necrotizing 
retinitis with a characteristic ophthalmoscopic appearance; it is usually unilateral, but if 
left untreated, it may progress to the contralateral eye and result in complete visual loss. 
CMV retinitis usually occurs as a result of hematogenous spread of the virus to the retina 
after systemic reactivation of a latent infection and usually in patients with severe 
deficiency of cell-mediated immunity. CMV retinitis has rarely been described in medical 
literature in settings of acute leukemia without autologus or allogenic HSCT. Here we 
present a case report of a patient with acute lymphoblastic leukemia who developed 2 
different ocular infections during treatment: fungal retinitis in the right eye during 
induction chemotherapy and CMV retinitis during consolidation chemotherapy. 
Case Report 
A 49-year-old gentleman from Iraq, a known carrier of the β-thalassemia trait, presented on March 
2007 with fever and symptomatic anemia. Complete blood count (CBC) showed pancytopenia, white 
blood cell (WBC) count was 3.2 × 10
3/μl, hemoglobin (Hb) 5.8 g/dl, mean corpuscular volume (MCV) 
60.7 fl, platelets (PLT) 46 × 10
3/μl, neutrophils 1.0 × 10
3/μl and lymphocyte count 2.1 × 10
3/μl. 
Peripheral smear was unremarkable apart from microcytic hypochromic anemia and absolute 
neutropenia. Bone marrow aspiration and biopsy showed hypercellular marrow with 95% of nucleated 
cells being blasts of lymphoid features. Immunophenotyping confirmed the diagnosis of B-cell common 
acute lymphoblastic leukemia (ALL). Karyotype was normal. Molecular studies were not available. 
Cerebrospinal fluid was not involved. Coagulation, kidney and liver functions were normal. 
Autoimmune screen was negative. Serologies for hepatitis B, C and human immunodeficiency virus 
(HIV) were negative. Viral serology was positive for CMV IgG 2,000 IU/ml and toxoplasma IgG 7.5 
IU/ml. Chest X-ray and abdominal ultrasound were normal. Echocardiography was normal and the 
ejection fraction was 55% (55–70). We started induction chemotherapy using the German ALL protocol 
(prednisolone, cyclophosphamide, vincristine, doxorubicin, L-asparaginase) through a Hickman line. 
During induction, the patient developed severe mucositis grade IV and prolonged neutropenia less than 
0.2 × 10
3/μl for which he was receiving multiple blood and PLT transfusions. He also had febrile 
neutropenia which was treated empirically with intravenous meropenem and vancomycin. His blood 
culture grew Candida albicans; therefore, caspofungin was added and the central line was removed. 
After 2 weeks on these antimicrobials, the patient still had a fever. A workup to exclude secondary 
candida foci was done, included echocardiography, which showed no vegetations, and imaging of the 
chest and abdomen which was normal. A retinal examination was performed by the ophthalmologist 
and showed left-sided focal retinitis superotemporal to the macula sparing visual acuity, most likely 
secondary to candida infection. There were no satellite lesions and no vitritis (fig. 1). Caspofungin was 
replaced with intravenous amphotericin B for a better ocular penetration and 2 weeks later the retinitis 
healed leaving a scar (fig. 2). The patient achieved hematological remission; however, he developed 
severe hepatic impairment and progressed to fulminant hepatic failure. Liver biopsy suggested a drug-
induced etiology and confirmed absence of fungal deposits. He received maximum supportive care till 
complete normalization of the liver function. L-asparaginase was presumed the most likely agent to 
have caused the hepatic toxicity; therefore, we shifted the patient to a hyper-CVAD regimen (course A: 
dexamethasone, vincristine, doxorubicin alternating with course B: high-dose methotrexate and high-
dose cytarabine). After the 4th course of hyper-CVAD the patient reported a decrease in vision in the 
opposite eye (left side) with floaters. His visual acuity reduced from normal to 6/24 in the left eye (best 
corrected) and remained normal in the right eye. There was no afferent pupillary defect. Fundus showed 
active hemorrhagic retinitis suggestive of CMV infection more in the left eye (fig. 3). The plasma CMV 
polymerase chain reaction (PCR) was 15 copies and continued to rise till 138 copies. The patient was 
started on intravenous ganciclovir 5 mg/kg b.i.d. for 3 weeks followed by maintenance with oral 
valganciclovir 900 mg b.i.d. for 2 months. His visual acuity improved to 6/9 in the left eye and retinitis 
resolved (fig. 4). During the 5th course of hyper-CVAD (October 2007), the patient had a sudden 
headache and progressed rapidly to coma. Computer tomography of the brain showed a large subdural 
hemorrhage with midline shift. Urgent surgical evacuation was done. This resulted in the patient  
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regaining full consciousness. However, he sustained residual right-sided spastic hemiparesis and started 
an intensive rehabilitation program including speech therapy, physiotherapy and occupational therapy. 
Maintenance chemotherapy was started on February 2008 with 6-mercaptopurine 60 mg/m
2 daily 
and methotrexate 20 mg/m
2 weekly. At the 24-month follow-up (February 2010), CBC was normal with 
WBC 6.6 × 10
3/μl, absolute neutrophil count (ANC) 4.3 × 10
3/μl, Hb 11.9 g/dl and PLT 315 × 10
3/μl. 
The patient was in complete remission with fair neurological recovery and stable visual acuity. 
Discussion 
The retinal involvement in acute leukemia may be of different causes like direct 
leukemic infiltrates, or secondary to vitreous and retinal hemorrhage caused by anemia, 
thrombocytopenia or hyperviscosity [2, 3]. Patients with acute leukemia are also 
susceptible to opportunistic – particularly viral, protozoal and fungal – infections that 
may involve the retina, especially during the periods of neutropenia, [3]. Candida 
infection is among the common infections in this subset of patients; when it involves the 
retina, it typically appears as focal, deep white lesions that can be singular or multiple. It 
may extend into the vitreous and cause vitritis and endophthalmitis. The rate of 
developing chorioretinitis in patients with candidemia has reduced markedly since the 
1990’s due to the early identification of candidemia in blood cultures coupled with a trend 
of early empiric antifungal therapy. The risk of ocular involvement is increased with 
Candida albicans compared with other candida species, as well as in multiple positive 
blood cultures or in the immunosuppressed states [4]. Cytomegalovirus infection is also 
among the common viral infections in the immunocompromised hosts. However, the 
prevalence of CMV antigenemia and disease in patients with hematological malignancies 
who are not transplant recipients or HIV infected is largely
 unknown and is thought to be 
low [5–8]. One retrospective cohort by Han [9] looked into the incidence of CMV 
antigenemia in more than 2,000 patients with hematological malignancies who did not 
undergo autologous or allogenic stem cell transplantation. They were tested during the 
antineoplastic treatment. The antigenemia rate was 13.6% in lymphoid malignancies and 
3.9% in myeloid malignancies.This suggests that CMV reactivation occurs primarily in 
situations of severe lymphoid disease. Another retrospective case series by Ng et al. [10] 
looked into the rate of CMV reactivation according to the type of therapy prior to CMV 
antigenemia in patients with hematological malignancies without HSCT. The series 
showed that the highest event rate was for alemtuzumab therapy 50%, 9.7% for the hyper-
CVAD regimen, 4.6% for fludarabine-based regimens, 4.2% for autologous stem cell 
transplantation, and less than 1% for other conventional chemotherapy regimens. The 
lung and gastrointestinal tract were the main organs affected with CMV disease in this 
series. 
The diagnosis of CMV end organ disease is most definitively made by the detection of 
CMV DNA or RNA in tissues by in situ hybridization. However, in cases of retinitis, 
retinal biopsy is not often recommended because of the high risk of retinal detachment. 
Accordingly, examining the intraocular fluid by PCR technique is the most specific mode 
for diagnosis [11]. The value of virus detection using blood culture or blood PCR may, on 
the other hand, have a strong correlation to the development of CMV retinitis as 
suggested by many studies in patients with AIDS [12, 13]. In our case, CMV retinitis was 
suggested by the typical ophthalmoscopic appearance of CMV hemorrhagic retinitis 
along with the concomitant rising of plasma CMV DNA by PCR and the remarkable 
improvement of retinal examination after resolution of the leucopenia and starting 
ganciclovir. Intraocular fluid sampling was not done because the patient was severely 
thrombocytopenic and had high a bleeding tendency in spite of PLT transfusions.  
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Possible factors that predisposed our patient for developing CMV retinitis are: the 
immunosuppression secondary to the disease itself and to the myeloablative 
chemotherapy of ALL that caused prolonged leukopenia. In addition, the high dose of 
steroids in the hyper-CVAD regimen aggravated the myelosuppression even more. The 
CMV infection in our patient may have developed due to the reactivation of the virus 
since the patient was seropositive for CMV before starting chemotherapy, or it may have 
been a new transmission from blood transfusions. The patient was HIV negative, so CD4 
count was not done initially or during the chemotherapy, but it was definitely very low 
during the treatment since total WBC count was 0.1–0.4 × 10
3/μl. CD4 count was done 
after bone marrow recovery and was normal. 
Conclusion 
CMV retinitis is rare in patients with acute leukemia receiving conventional 
chemotherapy without HSCT, yet it can occur, particularly when the treatment includes a 
large dose of steroids like in the hyper-CVAD protocol. Moreover, ocular infections in 
this subgroup of patients can be asymptomatic. Therefore, an eye examination by an 
ophthalmologist, even in the absence of ocular symptoms, is of importance during the 
treatment of these patients. 
 
 
 
 
 
Fig. 1. Color photograph of the right fundus showing focal hemorrhagic retinitis superotemporal to 
macula (candida retinitis). 
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Fig. 2. Color photograph of the right fundus 2 weeks after starting intravenous amphotericin B: focal 
retinitis healed leaving a scar. 
 
 
 
Fig. 3. Color photo of the left fundus showing white fluffy lesions in the temporal macula surrounding 
retinal vessels associated with hemorrhage (CMV retinitis). 
 
 
 
Fig. 4. Right and left fundi show healed retinal scars corresponding to the site of the previous retinitis 
(right fungal retinitis and bilateral CMV retinits). 
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